Biomarkers in sepsis

Purpose of review This review discusses the current developments in biomarkers for sepsis. Recent findings With quantum leaps in technology, an array of biomarkers will become available within the next decade as point-of-care tools that will likely revolutionize the management of sepsis. These markers will facilitate early and accurate diagnosis, faster recognition of impending organ dysfunction, optimal selection and titration of appropriate therapies, and more reliable prognostication of risk and outcome. These diagnostics will also enable an improved characterization of the biological phenotype underlying sepsis and thus a better appreciation of the condition. Summary The potential for novel biomarkers in sepsis will need to be properly realized with considerable funding, academic–industry collaborations, appropriate investigations and validation in heterogenous populations, but these developments do hold the capacity to transform patient care and outcomes.

[1]  F. Massin,et al.  Combination biomarkers to diagnose sepsis in the critically ill patient. , 2012, American journal of respiratory and critical care medicine.

[2]  Jürgen Popp,et al.  Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis , 2012, PLoS medicine.

[3]  C. Natanson,et al.  Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia , 2012, Intensive Care Medicine.

[4]  D. Maslove,et al.  Identification of sepsis subtypes in critically ill adults using gene expression profiling , 2012, Critical Care.

[5]  D. Ledoux,et al.  Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients* , 2012, Critical care medicine.

[6]  O. Tasaki,et al.  Prognostic impact of fecal pH in critically ill patients , 2012, Critical Care.

[7]  I. Guessous,et al.  Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management , 2012, Critical Care.

[8]  Taka-aki Nakada,et al.  Normal-Range Blood Lactate Concentration in Septic Shock Is Prognostic and Predictive , 2012, Shock.

[9]  Andrew Rhodes,et al.  Drotrecogin alfa (activated) in adults with septic shock. , 2012, The New England journal of medicine.

[10]  Fei Wang,et al.  Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis , 2012, Critical Care.

[11]  C. Sprung,et al.  Diastolic dysfunction and mortality in severe sepsis and septic shock. , 2012, European heart journal.

[12]  J. Ge,et al.  Relationship between thyroid function and ICU mortality: a prospective observation study , 2012, Critical Care.

[13]  Biologic drugs set to top 2012 sales , 2012, Nature Medicine.

[14]  Derek C Angus,et al.  The search for effective therapy for sepsis: back to the drawing board? , 2011, JAMA.

[15]  B. Nadjm,et al.  Point-of-care measurement of blood lactate in children admitted with febrile illness to an African District Hospital. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  P. L. Petersen,et al.  Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial* , 2011, Critical care medicine.

[17]  R. Agarwal,et al.  Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Kellum,et al.  Urinary biomarkers and renal recovery in critically ill patients with renal support. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[19]  Benjamin Tang,et al.  Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis , 2011, Critical care.

[20]  Alison Fox-Robichaud,et al.  Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis* , 2011, Critical care medicine.

[21]  J. Vincent,et al.  Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated) , 2010, Critical care.

[22]  J. Weitz,et al.  Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock. , 2010, The Journal of surgical research.

[23]  B. Mougin,et al.  EARLY ASSESSMENT OF LEUKOCYTE ALTERATIONS AT DIAGNOSIS OF SEPTIC SHOCK , 2010, Shock.

[24]  M. Singer,et al.  Survival in critical illness is associated with early activation of mitochondrial biogenesis. , 2010, American journal of respiratory and critical care medicine.

[25]  Yanping Wang,et al.  Troponin-I as a prognosticator of mortality in severe sepsis patients. , 2010, Journal of critical care.

[26]  C. Sprung,et al.  Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock , 2009, Intensive Care Medicine.

[27]  J. Granger,et al.  Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis* , 2009, Critical care medicine.

[28]  Munish Goyal,et al.  A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis , 2009, Critical care medicine.

[29]  M. J. Pearce,et al.  Presymptomatic Prediction of Sepsis in Intensive Care Unit Patients , 2008, Clinical and Vaccine Immunology.

[30]  M. Matthay,et al.  Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury , 2008, Critical care.

[31]  D. Hoyer,et al.  Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome* , 2008, Critical care medicine.

[32]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[33]  John A Kellum,et al.  Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. , 2007, Archives of internal medicine.

[34]  T. Holland-Letz,et al.  Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study , 2007, Critical care.

[35]  K. Larsen,et al.  Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study , 2007, Critical care.

[36]  Anthony S McLean,et al.  Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.

[37]  F. Di Maggio,et al.  BIOMARKERS OF ACUTE RENAL INJURY AND RENAL FAILURE , 2006, Shock.

[38]  G. Bernard,et al.  Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome , 2006, Critical care.

[39]  P. Collinson,et al.  Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients , 2006, Critical care.

[40]  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[41]  John Land,et al.  Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.

[42]  D. Annane,et al.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.

[43]  M. Jiménez,et al.  Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. , 1999, The Journal of infectious diseases.

[44]  C. Sprung,et al.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.

[45]  Jonathan Cohen,et al.  A prospective study of fever in the intensive care unit , 1999, Intensive Care Medicine.

[46]  C. Hinds,et al.  Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. , 1997, Critical care medicine.

[47]  K. Asadullah,et al.  Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.

[48]  J E Parrillo,et al.  Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. , 1987, Critical care medicine.

[49]  F. Massin,et al.  Combination biomarkers to diagnose sepsis in the critically ill patient. , 2012, American journal of respiratory and critical care medicine.

[50]  Fei Wang,et al.  Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis , 2012, Critical Care.

[51]  Jürgen Popp,et al.  Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis , 2012, PLoS medicine.

[52]  C. Natanson,et al.  Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia , 2012, Intensive Care Medicine.

[53]  D. Maslove,et al.  Identification of sepsis subtypes in critically ill adults using gene expression profiling , 2012, Critical Care.

[54]  D. Ledoux,et al.  Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients* , 2012, Critical care medicine.

[55]  O. Tasaki,et al.  Prognostic impact of fecal pH in critically ill patients , 2012, Critical Care.

[56]  I. Guessous,et al.  Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management , 2012, Critical Care.

[57]  Taka-aki Nakada,et al.  Normal-Range Blood Lactate Concentration in Septic Shock Is Prognostic and Predictive , 2012, Shock.

[58]  Andrew Rhodes,et al.  Drotrecogin alfa (activated) in adults with septic shock. , 2012, The New England journal of medicine.

[59]  Fei Wang,et al.  Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis , 2012, Critical Care.

[60]  Melinda Wenner Moyer,et al.  Targeting hypoxia brings breath of fresh air to cancer therapy , 2012, Nature Medicine.

[61]  C. Sprung,et al.  Diastolic dysfunction and mortality in severe sepsis and septic shock. , 2012, European heart journal.

[62]  J. Ge,et al.  Relationship between thyroid function and ICU mortality: a prospective observation study , 2012, Critical Care.

[63]  Biologic drugs set to top 2012 sales , 2012, Nature Medicine.

[64]  Derek C Angus,et al.  The search for effective therapy for sepsis: back to the drawing board? , 2011, JAMA.

[65]  B. Nadjm,et al.  Point-of-care measurement of blood lactate in children admitted with febrile illness to an African District Hospital. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[66]  P. L. Petersen,et al.  Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial* , 2011, Critical care medicine.

[67]  R. Agarwal,et al.  Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[68]  J. Kellum,et al.  Urinary biomarkers and renal recovery in critically ill patients with renal support. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[69]  Benjamin Tang,et al.  Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis , 2011, Critical care.

[70]  Alison Fox-Robichaud,et al.  Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis* , 2011, Critical care medicine.

[71]  J. Vincent,et al.  Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated) , 2010, Critical care.

[72]  J. Weitz,et al.  Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock. , 2010, The Journal of surgical research.

[73]  B. Mougin,et al.  EARLY ASSESSMENT OF LEUKOCYTE ALTERATIONS AT DIAGNOSIS OF SEPTIC SHOCK , 2010, Shock.

[74]  M. Singer,et al.  Survival in critical illness is associated with early activation of mitochondrial biogenesis. , 2010, American journal of respiratory and critical care medicine.

[75]  Yanping Wang,et al.  Troponin-I as a prognosticator of mortality in severe sepsis patients. , 2010, Journal of critical care.

[76]  T. Baumann,et al.  Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. , 2009, American journal of respiratory and critical care medicine.

[77]  C. Sprung,et al.  Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock , 2009, Intensive Care Medicine.

[78]  J. Marshall,et al.  Biomarkers of sepsis , 2009, Critical care medicine.

[79]  J. Granger,et al.  Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis* , 2009, Critical care medicine.

[80]  Munish Goyal,et al.  A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis , 2009, Critical care medicine.

[81]  M. J. Pearce,et al.  Presymptomatic Prediction of Sepsis in Intensive Care Unit Patients , 2008, Clinical and Vaccine Immunology.

[82]  M. Matthay,et al.  Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury , 2008, Critical care.

[83]  D. Hoyer,et al.  Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome* , 2008, Critical care medicine.

[84]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[85]  L. Trinquart,et al.  Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure* , 2007, Critical care medicine.

[86]  John A Kellum,et al.  Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. , 2007, Archives of internal medicine.

[87]  T. Holland-Letz,et al.  Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study , 2007, Critical care.

[88]  K. Larsen,et al.  Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study , 2007, Critical care.

[89]  Anthony S McLean,et al.  Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.

[90]  F. Di Maggio,et al.  BIOMARKERS OF ACUTE RENAL INJURY AND RENAL FAILURE , 2006, Shock.

[91]  J. Schiettecatte,et al.  Elevated serum levels of S-100&bgr; protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock* , 2006 .

[92]  G. Bernard,et al.  Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome , 2006, Critical care.

[93]  P. Collinson,et al.  Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients , 2006, Critical care.

[94]  J. Schiettecatte,et al.  Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. , 2006, Critical care medicine.

[95]  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[96]  John Land,et al.  Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.

[97]  D. Annane,et al.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.

[98]  M. Jiménez,et al.  Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. , 1999, The Journal of infectious diseases.

[99]  C. Sprung,et al.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.

[100]  Jonathan Cohen,et al.  A prospective study of fever in the intensive care unit , 1999, Intensive Care Medicine.

[101]  C. Hinds,et al.  Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. , 1997, Critical care medicine.

[102]  K. Asadullah,et al.  Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.

[103]  J E Parrillo,et al.  Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. , 1987, Critical care medicine.